Is Poorly Assisted Psilocybin Treatment an Increasing Risk?
American Journal of Psychiatry January 1, 2024 Eduardo Ekman Schenberg, Franklin King, João Eusébio Da Fonseca et al. 31 citations
Psilocybin has shown remarkable potential in psychiatry, with a study involving 100 participants revealing that 70% experienced significant reductions in anxiety and depression symptoms after treatment. This psychedelic compound, derived from mushrooms, is gaining traction in psychoanalysis and psychology for its therapeutic effects. Psychotherapists are increasingly scrutinizing its efficacy compared to traditional therapies. The chemical synthesis of psilocybin and its alkaloids could revolutionize mental health treatment, offering new avenues for those struggling with severe psychological conditions.